---

---

tags : Fda    crawled time : 05:00   

save search

---

Roche granted FDA Breakthrough Device Designation for blood test to support earlier Alzheimer's disease diagnosis
Published: 2024-04-11 (Crawled : 05:00) - globenewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| -3.4% | O: 1.06% H: 0.47% C: -0.03%
fda device disease test granted blood designation for alzheimer's roche

---

FDA Action Alert: Vanda, Basilea and J&J/Legend
Published: 2024-04-01 (Crawled : 05:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -6.48% | O: -0.28% H: 0.27% C: 0.04%
fda

---

FDA Action Alert: Mirum, BMS, Madrigal and More
Published: 2024-03-11 (Crawled : 05:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -6.94% | O: 0.43% H: 0.0% C: 0.0%
fda

---

FDA Adcomm to Tackle Complexity of CAR-T for Multiple Myeloma
Published: 2024-03-11 (Crawled : 05:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -6.94% | O: 0.43% H: 0.0% C: 0.0%
fda car-t

---

FDA Action Alert: Argenx, Aldeyra, Intercept and Sarepta
Published: 2023-06-19 (Crawled : 05:00) - biospace.com/
ARGX | $360.11 0.47% 0.47% 330K |

Health Technology

| Email alert Add to watchlist
fda

---

FDA Action Alert: Merck, Sanofi/AstraZeneca and Eisai/Biogen
Published: 2023-06-05 (Crawled : 05:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -8.08% | O: 0.4% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -8.8% | O: 0.45% H: 0.0% C: 0.0%
fda

---

FDA Action Alert: Amylyx's Moment of Truth and Dupixent Seeks another Nod
Published: 2022-09-26 (Crawled : 05:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| 26.36% | O: 5.77% H: 0.0% C: -2.27%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| 20.64% | O: -2.29% H: 0.35% C: -0.67%
fda dupixent

---

FDA Review: Immusoft, BioCryst, Intellia and More
Published: 2022-09-05 (Crawled : 05:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| Email alert Add to watchlist
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| Email alert Add to watchlist
fda

---

Incyte Announces U.S. FDA Approval of Opzelura™ (ruxolitinib) Cream for the Treatment of Vitiligo
Published: 2022-07-19 (Crawled : 05:00) - biospace.com/
INCY | $52.3 -0.98% -0.99% 2.2M |

Health Technology

| -34.97% | O: -0.83% H: 0.0% C: 0.0%
treatment fda approval

---

Breakthrough radiology AI provider annalise.ai appoints proven global healthcare leader as CEO, officially launches US team following FDA clearances
Published: 2022-07-05 (Crawled : 05:00) - prnewswire.com
HCA 4 | $305.11 2.73% -0.0% 1.5M |

Health Services

| 74.29% | O: -0.99% H: 0.16% C: -0.43%
fda

---

Acer Therapeutics Readies for FDA Ruling on UCDs Drug
Published: 2022-05-30 (Crawled : 05:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| Email alert Add to watchlist
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| Email alert Add to watchlist
fda drug therapeutics

---

FDA Authorizes Marketing of 22nd Century Group’s VLN® as a Modified Risk Tobacco Product
Published: 2021-12-24 (Crawled : 05:00) - globenewswire.com
XXII 4 | $1.62 -5.26% -5.56% 340K |

Health Technology

| Email alert Add to watchlist
vln fda risk group

---

FDA Approves Two New Indications for XARELTO® (rivaroxaban) to Help Prevent and Treat Blood Clots in Pediatric Patients
Published: 2021-12-21 (Crawled : 05:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -11.83% | O: 0.18% H: 0.02% C: -0.51%
xarelto fda blood

---

U.S. FDA Approves PREVNAR 20™, Pfizer’s Pneumococcal 20-valent Conjugate Vaccine for Adults Ages 18 Years or Older
Published: 2021-06-09 (Crawled : 05:00) - biospace.com/
PFE A | $26.0 2.4% -0.15% 38M |

Health Technology

| -33.08% | O: 0.39% H: 2.15% C: 2.08%
fda vaccine fda approval order pneumococcal

---

U.S. FDA Accepts Regulatory Submission for Sintilimab in Combination with Pemetrexed and Platinum Chemotherapy for the First-Line Treatment of People with Nonsquamous Non-Small Cell Lung Cancer
Published: 2021-05-18 (Crawled : 05:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 271.46% | O: -0.27% H: 0.69% C: -0.19%
treatment fda lung cancer therapy cancer submission fda acceptance

---

ChemoCentryx Announces Results of FDA Advisory Committee Meeting on Avacopan in ANCA-Associated Vasculitis
Published: 2021-05-07 (Crawled : 05:00) - globenewswire.com
CCXI | $51.99 -0.04% |

Health Technology

| 89.12% | O: -56.28% H: 1.08% C: -12.98%
fda results avacopan

---

KemPharm Announces FDA Approval of AZSTARYS™ (serdexmethylphenidate and dexmethylphenidate capsules, for oral use, CII), A New Once-Daily Treatment for ADHD
Published: 2021-03-03 (Crawled : 05:00) - globenewswire.com
KMPH | $5.46 6.04% 0 |

Manufacturing

| -37.54% | O: 67.23% H: 15.09% C: -14.58%
treatment fda fda approval adhd approval

---

Gainers vs Losers

67%

33%

Top 10 Gainers

AGBA | News | $1.26 215.0% 68.25% 130M |

Finance

EGOX | $0.0515 43.06% 30.1% 330M |

OLB 4 | $0.33 -14.95% 25.53% 840K |

Technology Services

NVFY | $2.77 31.28% 23.83% 33M |

Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M |

Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M |

Distribution Services

INSG | $3.03 25.21% 20.13% 330K |

Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K |

Manufacturing

WLGS | $0.59 18.0% 17.9% 2.3M |

ASNS | $0.828 21.75% 17.86% 18K |

---

Your saved searches

---